Overview
Geoffrey Gibney is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Gibney is rated as an Experienced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Sinus Cancer, and Olfactory Neuroblastoma.
His clinical research consists of co-authoring 87 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Uveal Melanoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3800 Reservoir Rd Nw, Washington, DC 20007
Additional Areas of Focus
Dr. Gibney has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
The Johns Hopkins Hospital
James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.
Medstar Medical Group Ii LLC
Suthee Rapisuwon is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Rapisuwon is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Renal Cell Carcinoma (RCC).
Medstar Medical Group Ii LLC
Michael Atkins is an Oncologist in Washington, Washington, D.c.. Dr. Atkins is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MelanomaDr. Gibney isElite. Learn about Melanoma.
- Advanced
- Merkel Cell CarcinomaDr. Gibney isAdvanced. Learn about Merkel Cell Carcinoma.
- Olfactory NeuroblastomaDr. Gibney isAdvanced. Learn about Olfactory Neuroblastoma.
- Sinus CancerDr. Gibney isAdvanced. Learn about Sinus Cancer.
- TeratocarcinosarcomaDr. Gibney isAdvanced. Learn about Teratocarcinosarcoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Gibney isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Gibney isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Gibney isExperienced. Learn about Anal Cancer.
- Angiosarcoma of the ScalpDr. Gibney isExperienced. Learn about Angiosarcoma of the Scalp.
- Basal Cell Skin CancerDr. Gibney isExperienced. Learn about Basal Cell Skin Cancer.
- Bone TumorDr. Gibney isExperienced. Learn about Bone Tumor.